These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 25526039)

  • 1. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
    Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
    PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.
    Yang X; Xu ZJ; Chen X; Zeng SS; Qian L; Wei J; Peng M; Wang X; Liu WL; Ma HY; Gong ZC; Yan YL
    World J Gastroenterol; 2019 May; 25(17):2099-2109. PubMed ID: 31114136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.
    Tóth K; Patai ÁV; Kalmár A; Barták BK; Nagy ZB; Galamb O; Wichmann B; Tulassay Z; Molnár B
    Pathol Oncol Res; 2017 Jul; 23(3):699-706. PubMed ID: 28035516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Methylated SEPT9 in Korean Colorectal Cancer Patients: Comparison with Previous Studies.
    Kim H; Lee JK; Hong YJ; Moon SM; Shin US; Kwon H; Shin K; Chang YH
    Clin Lab; 2018 Sep; 64(9):1573-1579. PubMed ID: 30273999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.
    Fu B; Yan P; Zhang S; Lu Y; Pan L; Tang W; Chen S; Chen S; Zhang A; Liu W
    Dis Markers; 2018; 2018():6437104. PubMed ID: 29849824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
    Hu J; Hu B; Gui YC; Tan ZB; Xu JW
    Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quantitative profiling of blood mSEPT9 determines the detection performance on colorectal tumors.
    Song L; Wang J; Wang H; Chen Y; Jia J; Guo S; Liu H; Peng X; Xiao W; Gong Y; Yang B; Lu Y; Li Y
    Epigenomics; 2018 Dec; 10(12):1569-1583. PubMed ID: 30426784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location.
    Song L; Jia J; Yu H; Peng X; Xiao W; Gong Y; Zhou G; Han X; Li Y
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1093-1101. PubMed ID: 28224298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers.
    Tóth K; Sipos F; Kalmár A; Patai AV; Wichmann B; Stoehr R; Golcher H; Schellerer V; Tulassay Z; Molnár B
    PLoS One; 2012; 7(9):e46000. PubMed ID: 23049919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Methylenetetrahydrofolate Reductase rs1801133 Gene Polymorphism with Cancer Risk and Septin 9 Methylation in Patients with Colorectal Cancer.
    Huang Y; Su T; Duan Q; Wei X; Fan X; Wan J; Liu L; Dian Z; Zhang G; Sun Y; Zhou T; Xu Y
    J Gastrointest Cancer; 2024 Jun; 55(2):778-786. PubMed ID: 38252186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery.
    Huang M; He J; Lai W; Liu L; Xu H; Zeng Y; Lan Q; Lin X; Chu Z
    BMC Gastroenterol; 2022 Feb; 22(1):87. PubMed ID: 35227194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening.
    Song L; Peng X; Li Y; Xiao W; Jia J; Dong C; Gong Y; Zhou G; Han X
    Epigenomics; 2017 May; 9(5):599-610. PubMed ID: 28470092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island.
    Wasserkort R; Kalmar A; Valcz G; Spisak S; Krispin M; Toth K; Tulassay Z; Sledziewski AZ; Molnar B
    BMC Cancer; 2013 Aug; 13():398. PubMed ID: 23988185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Significance of Septin 9 and Colon Cancer Specific Antigen-2 (CCSA-2) in Colorectal Cancer.
    Abd El Kader L; Soliman AH; Salem SE; Akel SY; Ibrahim NH
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):1027-1036. PubMed ID: 36974558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
    Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
    BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylated Septin 9 and Carcinoembryonic Antigen for Serological Diagnosis and Monitoring of Patients with Colorectal Cancer After Surgery.
    Ma ZY; Law WL; Ng EKO; Chan CSY; Lau KS; Cheng YY; Shin VY; Kwong A; Leung WK
    Sci Rep; 2019 Jul; 9(1):10326. PubMed ID: 31316143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer.
    Tóth K; Galamb O; Spisák S; Wichmann B; Sipos F; Valcz G; Leiszter K; Molnár B; Tulassay Z
    Pathol Oncol Res; 2011 Sep; 17(3):503-9. PubMed ID: 21267688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer.
    Song L; Guo S; Wang J; Peng X; Jia J; Gong Y; Yang B; Xiao W; Dong C; Liu H; Li Y
    Biomark Med; 2018 Sep; 12(9):961-973. PubMed ID: 30043648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.